Literature DB >> 16086621

Predictors of remission after electroconvulsive therapy in unipolar major depression.

Alexandre Y Dombrovski1, Benoit H Mulsant, Roger F Haskett, Joan Prudic, Amy E Begley, Harold A Sackeim.   

Abstract

CONTEXT: Electroconvulsive therapy (ECT) is the most effective biological treatment for major depression. However, there is little agreement about clinically useful predictors of acute ECT outcomes.
OBJECTIVE: To assess whether age, sex, burden of comorbid physical illness, age at onset, history of recurrence, episode duration, chronic depression or comorbid dysthymia, melancholic features, episode severity, and medication resistance are predictors of remission after an acute course of ECT.
DESIGN: We performed an analysis using data gathered prospectively in 328 patients with unipolar major depression (according to Research Diagnostic Criteria) treated with ECT. The study was conducted from 1993 through 1999. Patients had a pretreatment score of 21 or higher on the 24-item Hamilton Rating Scale for Depression (HAM-D). Treatment history was assessed using the Antidepressant Treatment History Form. Remission was defined as a 24-item HAM-D score of 10 or less and a 60% or more relative reduction of the HAM-D score.
RESULTS: On univariate logistic regression, statistically significant predictors of nonremission were chronic depression/dysthymia, medication resistance, longer episode duration, and younger age. On backward elimination logistic regression, only medication resistance (OR = 1.67, 95% CI = 1.05 to 2.67) and chronic depression/ dysthymia (OR = 1.84, 95% CI = 1.06 to 3.21) were statistically significant predictors of nonremission.
CONCLUSIONS: In patients with major depression, lower rates of remission after acute ECT are associated with medication resistance and chronicity, but not with age or burden of physical illness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086621     DOI: 10.4088/jcp.v66n0813

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  What is the role of brain stimulation therapies in the treatment of depression?

Authors:  Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

2.  Influence of depressed patients' expectations prior to electroconvulsive therapy on its effectiveness and tolerability (Exp-ECT): a prospective study.

Authors:  Lisa Krech; Michael Belz; Matthias Besse; Isabel Methfessel; Dirk Wedekind; David Zilles
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-09-22       Impact factor: 5.270

3.  Electroconvulsive therapy for treatment of major depression in a 100-year-old patient with severe aortic stenosis: a 5-year follow-up report.

Authors:  John P O'Reardon; Mario A Cristancho; Barbara Ryley; Kajal R Patel; Howard L Haber
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

4.  Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation.

Authors:  Jonathan H Hsu; Benoit H Mulsant; Eric J Lenze; Jordan F Karp; Helen Lavretsky; Steven P Roose; Charles F Reynolds; Daniel M Blumberger
Journal:  Am J Geriatr Psychiatry       Date:  2016-05-06       Impact factor: 4.105

Review 5.  Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia.

Authors:  Roger F Haskett; Colleen Loo
Journal:  J ECT       Date:  2010-09       Impact factor: 3.635

6.  Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.

Authors:  Daniel M Blumberger; Benoit H Mulsant; Chetachi Emeremni; Patricia Houck; Carmen Andreescu; Sati Mazumdar; Ellen Whyte; Anthony J Rothschild; Alastair J Flint; Barnett S Meyers
Journal:  J Psychiatr Res       Date:  2011-02-05       Impact factor: 4.791

7.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

8.  SMRI Biomarkers Predict Electroconvulsive Treatment Outcomes: Accuracy with Independent Data Sets.

Authors:  Rongtao Jiang; Christopher C Abbott; Tianzi Jiang; Yuhui Du; Randall Espinoza; Katherine L Narr; Benjamin Wade; Qingbao Yu; Ming Song; Dongdong Lin; Jiayu Chen; Thomas Jones; Miklos Argyelan; Georgios Petrides; Jing Sui; Vince D Calhoun
Journal:  Neuropsychopharmacology       Date:  2017-07-31       Impact factor: 7.853

9.  Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study.

Authors:  Axel Nordenskjöld; Lars von Knorring; Ingemar Engström
Journal:  BMC Psychiatry       Date:  2012-08-17       Impact factor: 3.630

10.  Subdural hematoma: an adverse event of electroconvulsive therapy-case report and literature review.

Authors:  Ranganath R Kulkarni; Sateesh Melkundi
Journal:  Case Rep Psychiatry       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.